The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Abstract Details
Activity Number:
|
652
|
Type:
|
Topic Contributed
|
Date/Time:
|
Thursday, August 4, 2011 : 10:30 AM to 12:20 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract - #300661 |
Title:
|
Two Examples on the Use of Simulations to Guide Model Selections in MMRM Analyses
|
Author(s):
|
Peiling Yang*+ and Phillip Dinh
|
Companies:
|
U.S. Food and Drug Administration and U.S. Food and Drug Administration
|
Address:
|
10903 New Hampshire Ave, Silver Spring, MD, 20993-0002,
|
Keywords:
|
Missing Data ;
MMRM ;
Simulation
|
Abstract:
|
Mixed model for repeated measures (MMRM) offers an alternative approach for dealing with missing data in longitudinal studies. The performance of the method has been demonstrated to be superior to the traditional ANCOVA analysis with missing data imputed by the Last Observation Carried Forward (LOCF) method under various scenarios. (See, for example, Mallinckrodt, et al. (2001, 2004), Molenberghs, et al. (2004), Lane, (2008), Siddiqui, et al. (2009)). However, MMRM analyses often have extra levels of complexity in terms of model specifications. In this talk, simulations will be used to guide the model specifications in two examples: 1. how to deal with titration visits in MMRM analyses and 2. how to handle baseline scores in MMRM analyses. Our simulations suggest that one should include all data (including titration visits) and should include a treatment-by-baseline interaction in an MMRM analysis. Examples from real schizophrenia trials will be used to contrast different methods.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2011 program
|
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.